# Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogeneic HSCT

> **NCT02873325** · — · TERMINATED · sponsor: **Cell Medica Ltd** · enrollment: 1 (actual)

## Conditions studied

- Infectious Complications Following HSCT

## Interventions

- **OTHER:** antiviral therapies for CMV and/or ADV

## Key facts

- **NCT ID:** NCT02873325
- **Lead sponsor:** Cell Medica Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05-11
- **Primary completion:** 2017-02-23
- **Final completion:** 2017-02-23
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Lack of study recruitment
- **Last updated:** 2018-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02873325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02873325, "Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogeneic HSCT". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02873325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*